Verified

Professor Carlos Ribeiro Award

Sociedade Portuguesa de Cardiologi

The Portuguese Society of Cardiology (SPC) had the privilege of having Professor Carlos Ribeiro (1926-2021) as one of its most brilliant and distinguished members. The ethical approach he took to medicine, the pedagogical importance he attributed to research in postgraduate medical training, and the institutional sense with which he led the SPC and fostered its internationalization, make him one of the most notable and influential figures in the history of our institution.

His academic brilliance, his solid humanistic background, and his pioneering vision on various dimensions of medicine made him a man ahead of his time. The creation of this Prize symbolizes the SPC's respect, admiration, and gratitude for the life and work of Professor Carlos Ribeiro, but also the wish that the knowledge of this illustrious and distinguished cardiologist may continue to inspire all SPC members.

Regulation

1. The “Professor Carlos Ribeiro Prize” will be awarded annually by the Portuguese Society of Cardiology (SPC) and will have a monetary value of 1,500 euros;

2. The Prize is intended to reward the best doctoral thesis defended by a member of the Portuguese Society of Cardiology (SPC) and whose content falls within the theme of Cardiovascular Medicine;

3. The author of the doctoral thesis must be a member of the SPC with admission for at least 12 months and in full use of their rights. Only doctoral theses presented and approved in the 12 months prior to the date of submission of the application (December 31st) may compete;

4. Applications must be sent by email to secretariado@spc.pt, by December 31st of each year, according to the following rules:
     a. Letter signed by the author of the doctoral thesis accepting the Scholarship Regulations;
     b. CV of the author of the doctoral thesis;
     c. Doctoral thesis submitted for the Prize.

5. Applications will be reviewed by the Jury and the winner will be announced during the Portuguese Cardiology Congress of the year following the date of submission of the application;

6. The awarding of the Prize is the sole responsibility of the SPC, which will appoint a Jury for this purpose;

7. The SPC Board will coordinate the receipt of applications and will verify, before the delivery of the originals to the Jury, whether the conditions of these regulations have been met. If they have not been met, the SPC Board will inform the candidates of this fact;

8. The Jury will consist of 3 doctoral members of the SPC, of recognized scientific merit, appointed for this purpose by the SPC Board, one of whom will be the President of the jury;
     a. Members of the Jury may not apply for the Scholarship;
     b. The Jury's decisions will be taken by an absolute majority of votes and there is no appeal;
     c. In case of a tie, the President of the Jury will have a casting vote;
     d. The jury must prepare a report stating its decision. This must be signed by all members of the jury and delivered to the SPC Board by March 30th of the year following the date of submission of the application.

9. The Jury's decision will be communicated in writing by the SPC Board to all candidates;

10. The prize money will be awarded to the winner after the Jury's decision during the Portuguese Cardiology Congress of the year following the date of submission of the application, at which the work must be presented in a Public Session;

11.For any and all situations not foreseen in these regulations, the SPC Board is responsible for their resolution; 12. The Jury may decide not to award the Prize, in which case its value will be allocated as the SPC Board sees fit.

12. The Jury may decide not to award the Prize, in which case its value will be allocated as the SPC Board sees fit.

AI Based Application Success Predictor

The ranking below is based on SPC's published rules for its research grants and awards. Exact criteria vary by program.

1

★★★★★

Direct cardiovascular relevance — Critical

The project should address cardiovascular disease, its mechanisms, prevention, diagnosis, treatment or patient outcomes. For the cardiomyopathy grant, the research must specifically concern myocardial or pericardial disease.

Sociedade Portuguesa de Cardiologia

2

★★★★★

Clinical significance and patient benefit — Critical

Demonstrate how the research could improve cardiovascular diagnosis, treatment, prevention, prognosis or quality of care. A clearly defined clinical problem strengthens the rationale.

3

★★★★★

Originality and scientific contribution — Critical

Identify a genuine knowledge gap and propose a meaningful advance. The SPC cardiomyopathy grant explicitly values originality and contribution to scientific knowledge.

Sociedade Portuguesa de Cardiologia

4

★★★★★

Methodological rigor — Critical

Present a clear hypothesis, appropriate study design, suitable outcomes, a defensible analysis plan and realistic methods. SPC's cardiomyopathy grant explicitly assesses methodological rigor.

Sociedade Portuguesa de Cardiologia

5

★★★★☆

Feasibility and implementation plan — Very high

Explain the study timeline, available resources, recruitment or data access, milestones and risks. The cardiomyopathy grant requires completion within 36 months; training fellowships have separate duration and reporting requirements.

Sociedade Portuguesa de Cardiologia

6

★★★★☆

Collaboration and multicentre potential — Very high

SPC's cardiomyopathy grant explicitly values collaboration across centres and gives preference to projects involving national institutions, including at least one clinical cardiology unit.

Sociedade Portuguesa de Cardiologia

7

★★★★☆

Applicant expertise and career development — Very high

Demonstrate relevant cardiovascular training, research capability and a credible development plan. For the Young Investigator Prize, the published eligibility rules include an age limit below 35, Portuguese nationality and SPC membership.

Sociedade Portuguesa de Cardiologia

8

★★★★☆

Potential to advance cardiovascular research — High

Show how the findings could improve scientific understanding, support future clinical studies, establish a research registry or contribute to better cardiovascular practice. SPC's CARE-PT initiative specifically aims to promote cardiovascular studies and national and international registries.

spc.pt

9

★★★☆☆

Clear presentation and scientific communication — High for awards

For the Young Investigator Prize, evaluation includes the abstract, oral presentation and discussion. Applicants should communicate the question, methods, findings and implications clearly and defend the work during questioning.

Sociedade Portuguesa de Cardiologia

10

★★★★☆

Eligibility and submission compliance — Essential gate

Confirm SPC membership, national institutional involvement, any age or nationality restrictions, submission deadlines, required documents and restrictions on overlapping SPC research funding.

Sociedade Portuguesa de Cardiologia

Ranked summary table

Rank	Predictor	Importance
1	Cardiovascular research relevance	Critical
2	Clinical importance	Critical
3	Originality	Critical
4	Methodological rigor	Critical
5	Feasibility	Very high
6	Collaboration across centres	Very high
7	Applicant capability and development	Very high
8	Contribution to cardiovascular research	High
9	Scientific presentation	High for prizes
10	Eligibility and compliance	Essential gate

Specialties

Cardiothoracic Surgery

Cardiovascular Diseases

Eligibility Requirements

. The Jury will consist of 3 doctoral members of the SPC, of recognized scientific merit, appointed for this purpose by the SPC Board, one of whom will be the President of the jury;
     a. Members of the Jury may not apply for the Scholarship;
     b. The Jury's decisions will be taken by an absolute majority of votes and there is no appeal;
     c. In case of a tie, the President of the Jury will have a casting vote;
     d. The jury must prepare a report stating its decision. This must be signed by all members of the jury and delivered to the SPC Board by March 30th of the year following the date of submission of the application.

Sponsor Details

Sponsor Institute/Organizations: Sociedade Portuguesa de Cardiologi

Sponsor Type: Corporate/Non-Profit

Address: Campo Grande 28, 13º piso, 1700-093 Lisbon

Legal & Affiliation Disclaimer

Affiliation Disclaimer: Trialect operates independently and is not affiliated with, endorsed by, or supported by any sponsors or organizations posting on the GrantsBoard platform. As an independent aggregator of publicly available funding opportunities, Trialect provides equal access to information for all users without endorsing any specific funding source, content, organization, or sponsor. Trialect assumes no responsibility for the content posted by sponsors or third parties.

Subscription Disclaimer: Upon logging into Trialect, you may choose to SUBSCRIBE to GrantsBoard for timely notifications of funding opportunities and to access exclusive benefits, such as priority alerts, reminders, personalized recommendations, and additional application support. However, users are advised to contact sponsors directly for any questions and are not required to subscribe to engage with funding opportunities.

Content Ownership and Copyright Disclaimer: Trialect respects the intellectual property rights of all organizations and individuals. All content posted on GrantsBoard is provided solely for informational purposes and remains the property of the original owners. Trialect does not claim ownership of, nor does it have any proprietary interest in, content provided by third-party sponsors. Users are encouraged to verify content and ownership directly with the posting sponsor.

Fair Use Disclaimer: The information and content available on GrantsBoard are compiled from publicly accessible sources in alignment with fair use principles under U.S. copyright law. Trialect serves as an aggregator of this content, offering it to users in good faith and with the understanding that it is available for public dissemination. Any organization or individual who believes their intellectual property rights have been violated is encouraged to contact us for prompt resolution.

Third-Party Posting Responsibility Disclaimer: Trialect is a neutral platform that allows third-party sponsors to post funding opportunities for informational purposes only. Sponsors are solely responsible for ensuring that their postings comply with copyright, trademark, and other intellectual property laws. Trialect assumes no liability for any copyright or intellectual property infringements in third-party content and will take appropriate action to address any substantiated claims.

Accuracy and Verification Disclaimer: Trialect makes no warranties regarding the accuracy, completeness, or reliability of the information provided by sponsors. Users are advised to verify the details of any funding opportunity directly with the sponsor before taking action. Trialect cannot be held liable for any discrepancies, omissions, or inaccuracies in third-party postings.

Notice and Takedown Policy: Trialect is committed to upholding copyright law and protecting the rights of intellectual property owners. If you believe that content on GrantsBoard infringes your copyright or intellectual property rights, please contact us with detailed information about the claim. Upon receipt of a valid notice, Trialect will promptly investigate and, where appropriate, remove or disable access to the infringing content.

View Funding Opportunity